Sanctuary Advisors LLC increased its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 13.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 111,271 shares of the company’s stock after acquiring an additional 13,434 shares during the period. Sanctuary Advisors LLC’s holdings in Colgate-Palmolive were worth $10,562,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Continuum Advisory LLC raised its position in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter worth approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive during the 3rd quarter valued at $64,000. Finally, Gradient Investments LLC grew its position in Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after acquiring an additional 400 shares during the last quarter. 80.41% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently commented on CL. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price target for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. Piper Sandler started coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target on the stock. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, TD Cowen cut their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $105.11.
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.34% of the stock is owned by insiders.
Colgate-Palmolive Stock Down 0.1 %
NYSE:CL opened at $93.44 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $75.50 and a twelve month high of $109.30. The company has a market cap of $76.34 billion, a PE ratio of 26.77, a P/E/G ratio of 3.31 and a beta of 0.43. The company’s 50 day moving average is $95.73 and its two-hundred day moving average is $98.58.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Basic Materials Stocks Investing
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- 5 Top Rated Dividend Stocks to Consider
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What Are Dividend Challengers?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.